Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −8,222 $36.67 $302K 38,254
2024-03-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −22,000 20,627
2024-03-01 Sturmer Michael E PRESIDENT Sale 10b5-1 −11,009 $36.63 $403K 141,738
2024-02-28 Swartz Allison EVP, GC Shares withheld for taxes −1,509 $40.79 $62K 53,083
2024-02-26 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes −224 $38.67 $9K 43,647
2024-02-26 Sturmer Michael E PRESIDENT Shares withheld for taxes −5,785 $38.67 $224K 152,747
2024-02-06 Sturmer Michael E PRESIDENT Sale 10b5-1 −2,260 $40.00 $90K 158,532
2024-02-05 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +20,000 $3.95 $79K 106,312
2024-02-05 Schlanger David J Executive Chairman Sale 10b5-1 −14,138 $38.35 $542K 92,174
2024-02-05 Schlanger David J Executive Chairman Sale 10b5-1 −5,862 $38.86 $228K 86,312
2024-02-05 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −20,000 1,390,022
2024-02-02 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +30,000 $3.95 $119K 116,312
2024-02-02 Schlanger David J Executive Chairman Sale 10b5-1 −16,741 $38.66 $647K 99,571
2024-02-02 Schlanger David J Executive Chairman Sale 10b5-1 −13,259 $39.24 $520K 86,312
2024-02-02 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −30,000 1,410,022
2024-02-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +22,000 $3.95 $87K 68,871
2024-02-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes 10b5-1 −12,349 $38.10 $470K 56,522
2024-02-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −9,651 $37.83 $365K 46,871
2024-02-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −3,000 $37.89 $114K 43,871
2024-02-01 Livingston Mark S. CHIEF FINANCIAL OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −22,000 42,627

Page 15 of 77 · 1,524 trades